Covered recipient · General Payments record
JESSICA LYN BROWN
Allopathic & Osteopathic Physicians Pediatrics Pediatric Pulmonology
General Payments · PY2018–2024
$5,065.00
- Reported across 179 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $459.11 | 15 |
| Education | $61.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BAXTER HEALTHCARE | $133.53 | 8 |
| JAZZ PHARMACEUTICALS INC. | $122.80 | 1 |
| Acerta Pharma LLC | $116.96 | 1 |
| HARMONY BIOSCIENCES LLC | $61.99 | 1 |
| GlaxoSmithKline, LLC. | $29.72 | 2 |
| Almatica Pharma Inc. | $22.14 | 1 |
| CSL Behring | $17.11 | 1 |
| Biogen, Inc. | $16.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Almatica Pharma LLC | $22.14 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137558525 | CMS |
| AstraZeneca Pharmaceuticals LP | $116.96 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104233649 | CMS |
| Baxter Healthcare | $33.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630341 | CMS |
| Baxter Healthcare | $21.08 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630337 | CMS |
| Baxter Healthcare | $5.89 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630339 | CMS |
| Baxter Healthcare | $6.66 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630335 | CMS |
| Baxter Healthcare | $6.16 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630333 | CMS |
| Baxter Healthcare | $6.37 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630331 | CMS |
| Baxter Healthcare | $25.45 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630343 | CMS |
| Baxter Healthcare | $28.04 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120630345 | CMS |
| Biogen, Inc. | $16.85 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872670 | CMS |
| CSL Behring | $17.11 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134621281 | CMS |
| GlaxoSmithKline, LLC. | $16.27 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115893840 | CMS |
| GlaxoSmithKline, LLC. | $13.45 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116242614 | CMS |
| HARMONY BIOSCIENCES LLC | $61.99 | 08/01/2024 | Education | Undisputed | 01/23/2026 | 1126055114 | CMS |
| JAZZ PHARMACEUTICALS INC. | $122.80 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150233938 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.